With so many blue chip ASX 200 shares for investors to choose from, it can be hard to decide which ones to buy.
To help narrow things down, I have picked out two that analysts at Citi rate as buys right now. They are as follows:
CSL Limited (ASX: CSL)
When it comes to blue chip ASX 200 shares, there are few that can compare to CSL.
It is one of the world's leading biotechnology companies, comprising the CSL Behring, CSL Vifor, and Seqirus businesses. These are leaders in their field and collectively generate strong revenue and earnings whatever is happening in the economy.
This could make CSL a particularly good option in the current uncertain economic environment.
Citi certainly believes this is the case. It currently has a buy rating and $350.00 price target on its shares. Its analysts note that this price target "implies CSL should trade on an FY25 PE of ~28x, in line with the 10-year average."
Goodman Group (ASX: GMG)
Another high-quality blue chip ASX 200 share that could be a buy is Goodman Group.
It is a leading integrated commercial and industrial property company that has $80.7 billion of total assets under management and a work in progress (WIP) pipeline valued at $13 billion. The company notes that the latter has high pre-commitment with its WIP 64% committed and completions for the 9 months 99% leased.
This shouldn't come as a big surprise, though. Management also highlights that demand remains very strong thanks to the "scarcity of assets and the complex planning and delivery environment for new space."
It is partly for this reason that analysts at Citi "see potential for GMG to generate consistent high-single to low-double digit earnings growth over the medium term."
The broker currently has a buy rating and $24.30 price target on Goodman's shares.
